Universidad de La Habana-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2024

  1. New insights into the role of VKORC1 polymorphisms for optimal warfarin dose selection in Caribbean Hispanic patients through an external validation of a population PK/PD model

    Biomedicine and Pharmacotherapy, Vol. 170

2020

  1. Genotype-driven pharmacokinetic simulations of warfarin levels in Puerto Ricans

    Drug Metabolism and Personalized Therapy

  2. Semi-mechanistic pharmacokinetic model to guide the dose selection of nimotuzumab in patients with autosomal dominant polycystic kidney disease

    Pharmaceutics, Vol. 12, Núm. 12, pp. 1-14

2018

  1. Semi-mechanistic Pharmacokinetic/Pharmacodynamic model of three pegylated rHuEPO and ior®EPOCIM in New Zealand rabbits

    European Journal of Pharmaceutical Sciences, Vol. 120, pp. 123-132